Alzheimer’s disease is a progressive memory disorder that affects nearly one in three seniors and is on the rise, currently affecting 43 million people worldwide.
Behind the memory impairments, there is a perfect storm of destruction in the brain, stemming in part from accumulations of a protein called tau. Normally a stabilizing structure inside of neurons, tau can accumulate in long tangles that disrupt the ability of neurons to communicate with one another.
University of New Mexico researchers have developed a vaccine that could prevent the formation of the tau tangles and potentially prevent the cognitive decline typically seen in Alzheimer’s patients.
In a paper published last week in NPJ Vaccines, the team reported it had engineered a vaccine using virus-like particles (VLPs, for short) that eliminated the tau tangles in mice that had been bred to develop symptoms like those affecting human Alzheimer’s patients.
“We’re excited by these findings, because they seem to suggest that we can use the body’s own immune system to make antibodies against these tangles, and that these antibodies actually bind and clear these tau tangles,” said Nicole Maphis, a PhD candidate in UNM’s Biomedical Sciences Graduate Program.
Maphis, working in the lab of Kiran Bhaskar, PhD, an associate professor in UNM’s Department of Molecular Genetics & Microbiology, found that when the vaccine was given to mice, they developed antibodies that cleared the tau protein from their brains – and the response lasted for months.
Then, she tested the animals in a battery of maze-like tests. Mice receiving the vaccination performed remarkably better than those that hadn’t. MRI scans showed that the vaccinated animals had less brain shrinkage, suggesting that the vaccine prevented neurons from dying.
Maphis also found significantly fewer tangles in both the cortex and the hippocampus – areas in the brain that are important for learning and memory, and which are destroyed in Alzheimer’s.
“These results confirm that targeting tau tangles using a vaccine intervention could rescue memory impairments and prevent neurons from dying,” Maphis said.
The vaccine was created with help from UNM scientists David Peabody and Bryce Chackerian. The pair helped pioneer the use of VLPs to create vaccines targeting dengue virus, hepatitis B, human papillomavirus and amyloid beta protein (which is also present in the brains of Alzheimer’s patients).
VLPs are derived from viruses that have their genomes removed, leaving only their outer protein shell. Lacking a genome, they’re unable to reproduce, but the body’s immune system still recognizes them as foreign invaders and manufactures antibodies to neutralize the proteins attached to their surface. In this case, a portion of tau protein on the surface of the VLP triggers an immune response, leading to the elimination of the tau tangles.
Going forward, Bhaskar hopes to obtain funding to commercialize this vaccine in order to create an injection that could potentially be tested in human patients. However, moving a drug from bench to bedside can cost millions of dollars and take decades.
By partnering with AgilVax, Inc., a company formed to commercialize the VLP technology, and STC.UNM (UNM’s technology commercialization arm), Bhaskar hopes to receive funding from a federal Small Business Innovation Research grant to help move the research project forward.
Learn more: Memory Preserver
The Latest on: Alzheimer’s vaccine
via Google News
The Latest on: Alzheimer’s vaccine
- California took on anti-vaxxers, and wonon July 4, 2019 at 1:58 am
"This is a great opportunity to compare the effects of similar vaccine legislation across states." Rural man’s innovation translates sign language into audio Is green tea a fad or a real health boost? ... […]
- Alzheimer’s research is getting a reboot at small companies focused on the immune systemon July 3, 2019 at 5:02 pm
The company said it is investigating two Alzheimer’s drugs, including a collaboration with a company called AC Immune that is developing a vaccine against tau protein tangles. Frank Heppner, one of ... […]
- Alzheimer's blood test almost 'usable in routine clinical care'on July 3, 2019 at 12:42 am
Alzheimer's is the most common type of dementia ... Gold nanoparticles promise safe cancer drugs, better vaccines A new study suggests that targeting B cells with gold nanoparticles could be a safe ... […]
- Is high LDL cholesterol tied to early-onset Alzheimer's?on July 2, 2019 at 4:34 am
Most early-onset Alzheimer's disease is not explained by known gene mutations ... much more common than you think This is why oral sex could be really bad for your health Anti-vaccine movement a ... […]
- The hunt for an Alzheimer's vaccineon July 1, 2019 at 5:07 am
We want to know what you think about the stories we discussed this week. Email [email protected] with your rants, raves and reviews. Join the WIRED Book Club! We're reading Angela Saini's Superior. ... […]
- With positive early results, team moves forward on Alzheimer's vaccineon June 30, 2019 at 10:10 pm
A research team at the University of New Mexico (UNM), Albuquerque, is moving forward with the development of a vaccine against tauopathies, a neurodegenerative class of diseases that includes ... […]
- ‘Medicare for All’ a big topic in second Dem debate & a vaccine advocate is targetedon June 28, 2019 at 5:29 pm
in a single photo Recommended Health care in the Dem debates & CDC panel… Health care in the Dem debates & CDC panel advises on key vaccines San Francisco’s e-cig ban & a Q&A with the… San Francisco’s ... […]
- UB-311: Could this vaccine protect against Alzheimer’s?on June 28, 2019 at 9:03 am
Most vaccines prepare our body’s immune system to fight off so-called exogenous disease, such as measles or flu, caused by bacteria or viruses entering our blood. Endobody vaccines, on the other ... […]
- Health care in the Dem debates & CDC panel advises on key vaccineson June 27, 2019 at 5:26 pm
there’s plenty of blame to go around Recommended ‘Medicare for All’ a big topic in second Dem… ‘Medicare for All’ a big topic in second Dem debate & a vaccine advocate is targeted San Francisco’s ... […]
- Researchers develop vaccine to possibly prevent Alzheimer’s diseaseon June 27, 2019 at 9:54 am
(KRQE) – As of now, a cure for Alzheimer’s Disease does not exist, but researchers at the University of New Mexico believe they have found a way to prevent it. “I really wanted to take this as a ... […]
via Bing News